US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

40.73

-0.0900-0.22%

Post-market: 40.730.00000.00%19:30 EDT

Volume:53.73K

Turnover:2.19M

Market Cap:1.04B

PE:- -

High:40.88

Open:40.82

Low:40.53

Close:40.82

52wk High:43.52

52wk Low:28.77

Shares:25.65M

Float Shares:25.65M

Volume Ratio:0.06

T/O Rate:0.21%

Dividend:0.29

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

J&J - Five-Year Overall Survival Rate 69.2%, Median Progression-Free Survival 60.5 Months

THOMSON REUTERS

FDA Approves Merck’s Welireg Plus Eisai’s Lenvima for Previously Treated Advanced Clear Cell Kidney Cancer

Surrozen price target raised to $54 from $44 at H.C. Wainwright

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029

France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain

Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update

FDA approves Welireg and Lenvima combo for ccRCC

Merck Shares Flat in Volume Spike After FDA Approves Kidney Drug, Last up 0.50% at $148.81

THOMSON REUTERS

FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Renal Cell Carcinoma with a Clear Cell Component

THOMSON REUTERS

Merck Has Two Overlooked Pipeline Catalysts Coming Before Year-End, UBS Says

MT Newswires Live

Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says

MT Newswires Live

BMY’s Lung Cancer Combo Study Completion Adds Quiet Support to Its Immuno-Oncology Pipeline

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

Alert on EOG CFO Appointment Incorrectly Tagged to J&J Withdrawn

EOG Resources Announces Ann Janssen's Retirement and Jeff Hibbard as Next CFO

THOMSON REUTERS

Merck's Drug for Diabetes-Related Eye Disease Meets Trial Goal

Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/FTXH/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":40.73,"timestamp":1790971200000,"preClose":40.82,"halted":0,"volume":53734,"hourTrading":{"tag":"盘后","latestPrice":40.73,"preClose":40.73,"latestTime":"19:30 EDT","volume":272,"amount":11072.918,"timestamp":1790983804654,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.002204801567858976,"floatShares":25650002,"shares":25650002,"eps":0,"marketStatus":"Market Closed","change":-0.09,"latestTime":"10-02 16:00:00 EDT","open":40.82,"high":40.8799,"low":40.53,"amount":2186414.643996,"amplitude":0.008572,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.82,"sharesOutstanding":850002,"nav":40.77,"aum":1045750581.54,"dividendRate":0.007076,"bidAskSpread":0.001075,"postHourTrading":{"tag":"盘后","latestPrice":40.73,"preClose":40.73,"latestTime":"19:30 EDT","volume":272,"amount":11072.918,"timestamp":1790983804654,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.05585346007718117,"impliedVol":0.216,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25650002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.05585346007718117,"shares":25650002,"dividePrice":0.2882,"high":40.8799,"amplitude":0.008572,"preClose":40.82,"low":40.53,"week52Low":28.77,"pbRate":"--","week52High":43.52,"institutionHeld":0,"latestPrice":40.73,"eps":0,"divideRate":0.007076,"volume":53734,"delay":0,"ttmEps":0,"open":40.82,"prevYearClose":32.9401,"prevWeekClose":41.67,"prevMonthClose":41.47,"prevQuarterClose":41.47,"fiveDayClose":41.67,"twentyDayClose":42.2181,"sixtyDayClose":38.8642},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-09-24","symbol":"FTXH","amount":0.0113,"announcedDate":"2026-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-24","defaultRemindTime":1790256600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-24","currency":"USD","dateTimestamp":1790222400000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670440474","title":"J&J - Five-Year Overall Survival Rate 69.2%, Median Progression-Free Survival 60.5 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440474?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:00","pubTimestamp":1790334004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1G2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1894683348.USD","MEDX","LU0345770993.USD","IE00BFXG1179.USD","BK4532","IHE","IE00BDGV0183.EUR","IE00BBT3K403.USD","LU0210536198.USD","FTXH","IXJ","IE00BKVL7J92.USD","JDOC","BMED","GDOC","LU0426412945.USD","LU0738911758.USD","LU0289961442.SGD","LU0949170772.SGD","TRUH","LU0689472784.USD","LU0511384066.AUD","LU2750360641.GBP","VHT","IYH","BK4585","LU0098860793.USD","LU2023250330.USD","FHLC","LU0985320562.USD","PJP","LU0545562505.USD","LU1196500208.SGD","LU2129689431.USD","RXL","LU1032466523.USD","SG9999013999.USD","LU0553294199.USD","LU1989771016.USD","XLV","LU1674673691.USD","JNJ","LU1732799900.SGD","LU0122379950.USD","LU2505996681.GBP","LU1261432733.SGD","LU1280957306.USD","LU1043141123.HKD","IE00BN8TJ469.HKD","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670544444","title":"FDA Approves Merck’s Welireg Plus Eisai’s Lenvima for Previously Treated Advanced Clear Cell Kidney Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670544444","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670544444?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:45","pubTimestamp":1790333155,"startTime":"0","endTime":"0","summary":"FDA approves Merck’s Welireg plus Eisai’s Lenvima for previously treated advanced clear cell kidney cancerFDA cleared Merck’s WELIREG with Eisai’s LENVIMA for previously treated adults with advanced clear cell renal cell carcinoma.Use targets patients whose disease progressed on a PD-1 or PD-L1 inhibitor.Phase 3 LITESPARK-011 showed median PFS of 14.6 months vs 10.6 months with cabozantinib; HR 0.74.Overall survival missed statistical significance at final analysis; objective response rate was 53% vs 40%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire  on September 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDL8yld87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN8TJ469.HKD","LU1291159041.SGD","LU0868494617.USD","IXJ","LU2023250504.SGD","LU1934455277.USD","LU0098860793.USD","BK4588","LU1571399168.USD","SG9999014567.USD","LU2461242641.AUD","SG9999015358.SGD","LU0289739343.SGD","LU0868494708.USD","BK4516","LU0965509283.SGD","GDOC","LU2360032135.SGD","SG9999013999.USD","LU0859254822.USD","LU1116320901.HKD","LU1989772840.SGD","LU0124676726.USD","LU0965508806.USD","IE0009355771.USD","LU0980610538.SGD","LU0238689110.USD","LU1093756168.USD","LU1061106388.HKD","LU2324357040.USD","SG9999002224.SGD","LU1430594728.SGD","LU2361044865.SGD","LU1941712264.USD","LU1037948897.HKD","LU0203347892.USD","LU0130102774.USD","LU0211331839.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4559","LU1069347547.HKD","LU0106261372.USD","LU2491050071.SGD","SG9999001176.SGD","LU2112291526.USD","LU1934455194.USD","PAWZ","HRTS","SG9999014559.SGD","LU0477156953.USD","LU0203345920.USD","LU0689626769.HKD","LU0057025933.USD","LU0965509010.AUD","LU1116320737.USD","LU1941712348.USD","BK4550","LU1974910355.USD","LU0070302665.USD","SG9999001176.USD","BK4533","LU2125909593.SGD","LU0208291251.USD","LU1066051225.USD","LU0965509101.SGD","LU1699723380.USD","IE000M9KFDE8.USD","FTXH","LU1989772923.USD","LU0648001328.SGD","MRK","SGXZ57979304.SGD","LU2023250843.SGD","LU0320765646.SGD","LU0861579265.USD","RXL","SG9999014542.SGD","LU0942090050.USD","LU0511384066.AUD","LU0006306889.USD","IE00B2B36J28.USD","JDOC","SG9999002232.USD","PPH","LU1989771016.USD","LU2468319806.SGD","LU2125909247.SGD","LU2361045086.USD","LU0234572021.USD","BK4585","LU1201861249.SGD","LU0130517989.USD","LU2125154935.USD","SG9999014575.USD","LU1037948541.HKD","LU0162691827.USD","LU0265550946.USD","TRUH","LU0823416689.USD","FHLC","LU0266013472.USD","LU1066051498.USD","IHE","LU1057294990.SGD","IE00BLSP4239.USD","SG9999015341.SGD","LU1934455863.HKD","IE00BSNM7G36.USD","LU1923622614.USD","BK4007","LU0472753341.HKD","SG9999001440.SGD","LU0289961442.SGD","LU1093756325.SGD","LU2491049909.HKD","LU1066051811.HKD","LU2433249047.HKD","LU2361044949.HKD","LU1929549753.HKD","LU2125154778.USD","BMED","LU1585245621.USD","LU0072461881.USD","LU0289739699.SGD","LU2357627491.SGD","LU0265550359.USD","IE00B1BXHZ80.USD","LU1023059063.AUD","LU0122379950.USD","LU1066053197.SGD","LU1983299246.USD","LU2106854487.HKD","XLV","IE00BBT3K403.USD","LU1032466523.USD","IYH","LU0069063385.USD","LU1917777945.USD","IE00BLSP4452.SGD","LU0985320562.USD","LU2491050154.USD","IE0002141913.USD","LU0058720904.USD","LU0432979614.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","BK4534","LU1035773651.USD","LU1162221912.USD","LU2089984988.USD","VHT","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444358","title":"Surrozen price target raised to $54 from $44 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444358?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:10","pubTimestamp":1790331041,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Surrozen (SRZN) to $54 from $44 and keeps a Buy rating on the shares. The firm believes Merck’s (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/surrozen-price-target-raised-to-54-from-44-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/surrozen-price-target-raised-to-54-from-44-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","LU2361044865.SGD","LU2491049909.HKD","RXL","LU1023059063.AUD","TRUH","LU2360032135.SGD","LU1037948897.HKD","LU0289961442.SGD","LU1069347547.HKD","LU0689626769.HKD","LU2125909247.SGD","LU1941712348.USD","LU1917777945.USD","PAWZ","LU0057025933.USD","BMED","LU2361045086.USD","SG9999002224.SGD","IXJ","LU1934455863.HKD","HRTS","LU0823416689.USD","LU0965508806.USD","LU0265550946.USD","LU1093756325.SGD","LU0070302665.USD","LU0208291251.USD","FTXH","LU1989772923.USD","LU1934455277.USD","BK4588","FHLC","LU2433249047.HKD","XLV","LU1923622614.USD","SRZN","SG9999015341.SGD","IYH","JDOC","VHT","IE00BLSP4239.USD","PPH","LU2361044949.HKD","LU0130102774.USD","LU1116320901.HKD","MRK","IHE","LU1093756168.USD","LU1035773651.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413314","title":"Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413314","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413314?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:55","pubTimestamp":1790283300,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  slipped 3.50% to $95.37 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Estee Lauder Cos. Cl A closed 21.59% below its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Procter & Gamble Co.  fell 1.16% to $145.68, and Coty Inc. Cl A  fell 0.38% to $2.63.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1066051811.HKD","LU0738911758.USD","JDOC","LU2264538146.SGD","LU1585245621.USD","LU1043141396.HKD","PG","TRUH","IE00BFTCPJ56.SGD","FSTA","SG9999014542.SGD","BK4533","MEDX","EL","RXL","BMED","GLAM","LU2347655156.SGD","LU2592432038.USD","LU1674673428.USD","IE00BBT3K403.USD","IE0034235303.USD","LU0553294199.USD","LU0942090050.USD","PJP","IE00BSNM7G36.USD","LU0057025933.USD","XLP","IHE","LU1914381329.SGD","FTXH","XLV","GDOC","IE00B1XK9C88.USD","IYH","LU0795875169.SGD","FHLC","LU2750360641.GBP","VHT","COTY","SG9999014575.USD","LU2552382132.HKD","TRUO","IE000BZT7R73.USD","LU0114720955.EUR","JNJ","UGE","IXJ","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670187634","title":"Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2670187634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670187634?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:32","pubTimestamp":1790281948,"startTime":"0","endTime":"0","summary":"Nanobiotix ( ($FR:NANO) ) just unveiled an announcement. Nanobiotix reported encouraging clinical progress for its lead nanoradioenhancer JNJ-1900 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","LU0070217475.USD","RXL","LU1894683348.USD","LU2756315664.SGD","JDOC","FHLC","IE00BDGV0183.EUR","IHE","FTXH","LU2756315318.SGD","LU0057025933.USD","LU2471134523.USD","PJP","IE00BLSP4452.SGD","LU2129689605.HKD","LU2133065610.SGD","IE000WAW04H5.SGD","LU2471134952.CNY","LU2750360641.GBP","NANO","GDOC","IYH","LU2089984988.USD","LU0795875169.SGD","LU0053666078.USD","LU1244550494.USD","LU1066051811.HKD","IE00B3T34201.USD","XLV","JNJ","LU0234572021.USD","LU0640476718.USD","VHT","LU1585245621.USD","LU0122379950.USD","TRUH","LU0098860793.USD","BK4007","BMED","BK4532","IE000SO60NU8.SGD","LU0820562030.AUD","LU2430703178.SGD","LU0466842654.USD","SG9999001440.SGD","LU0738911758.USD","LU2505996681.GBP","IXJ","LU1914381329.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670941892","title":"France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2670941892","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670941892?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:24","pubTimestamp":1790281482,"startTime":"0","endTime":"0","summary":"France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gainOverviewFrance-based biotech firm's H1 2026 revenue declined due to prior year one-off non-cash impactNet loss wide","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G12R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210528500.USD","LU2089984988.USD","VHT","XLV","IHE","LU2750360997.AUD","LU0072461881.USD","SG9999001176.SGD","LU0345769128.USD","FHLC","LU1032466523.USD","TRUH","LU1121112475.USD","MEDX","LU1221951046.USD","LU0345769631.USD","LU0792757196.USD","IYH","LU1506573853.SGD","JDOC","LU2112291526.USD","LU2430703251.USD","LU0545039389.USD","RXL","IE00B19Z3581.USD","LU0114720955.EUR","LU0162691827.USD","IE000WAW04H5.SGD","SGXZ57979304.SGD","LU2896262040.SGD","BMED","PJP","LU1496350502.SGD","LU0795875086.SGD","LU0289961442.SGD","BK4588","LU0949170772.SGD","IE0000B7K699.USD","LU1057294990.SGD","LU1162221912.USD","IE00BGHQF631.EUR","LU0889566641.SGD","IE00B4R5TH58.HKD","IXJ","JNJ","LU0098860793.USD","FTXH","IE0001KFT4U8.USD","GDOC","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670418519","title":"Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2670418519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670418519?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:15","pubTimestamp":1790280900,"startTime":"0","endTime":"0","summary":"-- Promising early results reported from full cohort analysis of the. completed dose-escalation and expansion phases of a Phase 1 study. recurrent non-small cell lung cancer  amenable to re-irradiation. -- Strengthened financial position through an oversubscribed EUR86 million. global follow-on offering completed in May 2026, extending cash runway. -- Acceptable safety profile and promising initial efficacy responses. observed in Johnson & Johnson-led Phase 2 CONVERGE study evaluating. Phase 3 NANORAY-312 study evaluating JNJ-1900  in locally. Anderson Cancer Center  presented at 2026 WCLC Meeting:. control rate was 79%. One-year local progression-free survival.  was 61%, and one-year overall survival  was 70% in. clinically meaningful local control using a substantially lower. -- All 24 patients completed treatment with JNJ-1900  plus","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","IE00BN8TJ469.HKD","BK4534","LU0234570918.USD","BK4139","LU1629891620.HKD","TRUH","IE00BVYPNW00.USD","JDOC","IE000SO60NU8.SGD","BK4559","SGXZ80539844.SGD","VHT","SG9999001176.SGD","JNJ","RXL","LU1066051225.USD","IYH","LU2756315664.SGD","IXJ","MEDX","SG9999001440.SGD","LU0994945656.USD","FHLC","LU0057025933.USD","IHE","LU0210528500.USD","PJP","LU1551013342.USD","LU0738911758.USD","LU0289739343.SGD","NBTX","SG9999001176.USD","SG9999013999.USD","LU0345769631.USD","LU0689472784.USD","LU1989771016.USD","GDOC","LU0345770308.USD","LU1894683264.USD","BK4007","XLV","LU0912757837.SGD","LU1674673428.USD","BMED","LU0234572021.USD","FTXH","IE00B19Z3581.USD","BK4532","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490795","title":"FDA approves Welireg and Lenvima combo for ccRCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490795","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490795?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:35","pubTimestamp":1790278513,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved Welireg from Merck (MRK) in combination with Lenvima from Eisai (ESAIY) for adults with advanced renal ce...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250504.SGD","LU2361044865.SGD","LU0980610538.SGD","IE00BLSP4452.SGD","BK4534","LU1941712264.USD","LU0072461881.USD","LU0203345920.USD","LU0823416689.USD","BK4550","LU0472753341.HKD","LU0122379950.USD","LU1989772923.USD","LU1069347547.HKD","SG9999014575.USD","SG9999002232.USD","LU1066053197.SGD","LU0265550946.USD","LU0266013472.USD","HRTS","LU0868494617.USD","LU0965508806.USD","LU0648001328.SGD","IE00BJT1NW94.SGD","IXJ","LU0320765489.SGD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU0432979614.USD","LU0511384066.AUD","LU1983299246.USD","LU1917777945.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1035773651.USD","PAWZ","LU1934455863.HKD","BMED","LU0070302665.USD","BK4588","LU0965509101.SGD","LU1989772840.SGD","LU0689626769.HKD","LU1066051811.HKD","LU1699723380.USD","LU1934455194.USD","LU0162691827.USD","LU0868494708.USD","SG9999015341.SGD","LU0942090050.USD","BK4007","SG9999014542.SGD","XLV","LU2461242641.AUD","LU2023250843.SGD","SG9999013999.USD","LU0238689110.USD","SGXZ57979304.SGD","LU2112291526.USD","FTXH","LU0965509283.SGD","LU1116320737.USD","LU2361045086.USD","LU1032466523.USD","LU0069063385.USD","LU0965509010.AUD","LU0203347892.USD","LU1974910355.USD","LU2491050154.USD","IE00BN8TJ469.HKD","LU2125154778.USD","LU1037948897.HKD","LU2433249047.HKD","BK4533","LU1037948541.HKD","LU0859254822.USD","LU1989771016.USD","MRK","SG9999014559.SGD","LU0289739343.SGD","LU2468319806.SGD","BK4516","LU1923622614.USD","LU0130517989.USD","LU0057025933.USD","LU2125909593.SGD","LU2491050071.SGD","LU2089984988.USD","LU0477156953.USD","LU0234572021.USD","GDOC","LU2125909247.SGD","IE00BFTCPJ56.SGD","LU2106854487.HKD","LU1201861249.SGD","TRUH","LU1585245621.USD","LU1057294990.SGD","ESAIY","LU0130102774.USD","IE00B4R5TH58.HKD","LU0265550359.USD","LU0985320562.USD","SG9999015358.SGD","IE00BJJMRZ35.SGD","LU1929549753.HKD","JDOC","LU0289739699.SGD","LU1093756325.SGD","SG9999014567.USD","LU2125154935.USD","LU0208291251.USD","LU1941712348.USD","BK4559","LU1093756168.USD","LU1162221912.USD","LU0106261372.USD","PPH","IHE","IE000M9KFDE8.USD","LU0006306889.USD","LU0861579265.USD","LU0211331839.USD","LU1430594728.SGD","LU1066051498.USD","VHT","SG9999002224.SGD","LU0058720904.USD","LU0289961442.SGD","BK4585","IYH","LU1291159041.SGD","LU1116320901.HKD","LU1061106388.HKD","LU2324357040.USD","SG9999001176.USD","IE00BLSP4239.USD","FHLC","LU0124676726.USD","LU1066051225.USD","LU2361044949.HKD","LU2491049909.HKD","RXL","LU2357627491.SGD","LU0320765646.SGD","LU1934455277.USD","SG9999001440.SGD","LU0098860793.USD","LU1023059063.AUD","SG9999001176.SGD","IE00BSNM7G36.USD","LU1571399168.USD","IE0009355771.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490194","title":"Merck Shares Flat in Volume Spike After FDA Approves Kidney Drug, Last up 0.50% at $148.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490194?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:28","pubTimestamp":1790278130,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL6N45G17P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2491049909.HKD","LU1699723380.USD","LU0124676726.USD","LU2491050071.SGD","LU0965509010.AUD","PPH","JDOC","FHLC","LU1917777945.USD","SG9999014542.SGD","LU1941712348.USD","SG9999015358.SGD","FTXH","LU2324357040.USD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0965508806.USD","LU2361044865.SGD","LU2361045086.USD","LU1430594728.SGD","LU2361044949.HKD","LU1032466523.USD","IE00BN8TJ469.HKD","LU2125154778.USD","IE0002141913.USD","LU1066051811.HKD","LU0965509101.SGD","IE0009355771.USD","LU1093756168.USD","IE00BSNM7G36.USD","BK4588","LU0859254822.USD","LU0320765646.SGD","LU1585245621.USD","LU0122379950.USD","LU0689626769.HKD","LU2357627491.SGD","LU2106854487.HKD","BK4533","IE00BJJMRZ35.SGD","BK4007","LU0211331839.USD","LU2125909247.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0162691827.USD","LU0265550359.USD","LU1571399168.USD","LU0289739343.SGD","RXL","LU1934455277.USD","LU1941712264.USD","IE000M9KFDE8.USD","LU0072461881.USD","LU1929549753.HKD","LU0472753341.HKD","LU2433249047.HKD","LU2112291526.USD","IE00BLSP4452.SGD","SG9999002224.SGD","LU0985320562.USD","LU2089984988.USD","BK4550","SG9999015341.SGD","IE00B2B36J28.USD","LU1037948541.HKD","LU0234572021.USD","SG9999014575.USD","SGXZ57979304.SGD","LU0868494617.USD","LU0942090050.USD","LU1023059063.AUD","LU1069347547.HKD","LU1923622614.USD","LU1162221912.USD","SG9999001440.SGD","LU1989772840.SGD","LU1093756325.SGD","SG9999001176.SGD","LU1989772923.USD","LU1116320901.HKD","LU0477156953.USD","LU0238689110.USD","LU1116320737.USD","LU0320765489.SGD","LU0130102774.USD","LU0965509283.SGD","LU0511384066.AUD","LU1061106388.HKD","LU0070302665.USD","LU2023250843.SGD","LU1974910355.USD","XLV","LU2491050154.USD","VHT","LU0106261372.USD","BK4534","PAWZ","SG9999002232.USD","LU1934455863.HKD","LU0289739699.SGD","HRTS","BMED","LU2125154935.USD","LU0006306889.USD","LU0289961442.SGD","LU0203347892.USD","SG9999013999.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999001176.USD","LU1983299246.USD","LU2468319806.SGD","LU0823416689.USD","BK4585","LU0265550946.USD","LU0069063385.USD","LU2023250504.SGD","LU0130517989.USD","LU1989771016.USD","IHE","LU0203345920.USD","LU0057025933.USD","LU1934455194.USD","LU2125909593.SGD","GDOC","IE00B4R5TH58.HKD","IYH","LU0648001328.SGD","LU0266013472.USD","SG9999014559.SGD","MRK","LU0432979614.USD","LU0868494708.USD","BK4516","LU0980610538.SGD","LU1037948897.HKD","LU0208291251.USD","SG9999014567.USD","IE00BJT1NW94.SGD","LU1035773651.USD","LU0058720904.USD","BK4559","LU2360032135.SGD","TRUH","LU0098860793.USD","LU1201861249.SGD","LU2461242641.AUD","LU1066053197.SGD","LU1066051498.USD","IXJ","LU0861579265.USD","LU1066051225.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490934","title":"FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Renal Cell Carcinoma with a Clear Cell Component","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490934?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:16","pubTimestamp":1790277398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G1BA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","LU1934455863.HKD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU2361044865.SGD","LU0965509010.AUD","SGXZ57979304.SGD","LU0320765489.SGD","IE00BSNM7G36.USD","LU2361044949.HKD","LU0203345920.USD","IYH","SG9999001176.SGD","BK4007","LU2106854487.HKD","LU1941712264.USD","IE00B2B36J28.USD","LU2125909247.SGD","LU1057294990.SGD","LU1989771016.USD","LU1923622614.USD","BK4550","LU0942090050.USD","LU1929549753.HKD","JDOC","LU1116320737.USD","LU0861579265.USD","LU1066051811.HKD","LU1699723380.USD","LU0289961442.SGD","LU0069063385.USD","LU0985320562.USD","BK4533","LU0098860793.USD","LU1093756168.USD","LU2361045086.USD","PPH","LU1066051225.USD","LU1201861249.SGD","LU0965509101.SGD","IE00BLSP4239.USD","LU1035773651.USD","LU1066053197.SGD","LU0106261372.USD","LU0238689110.USD","LU0124676726.USD","LU1023059063.AUD","LU1989772923.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","LU0432979614.USD","SG9999002232.USD","SG9999014559.SGD","LU2491050154.USD","LU0320765646.SGD","LU0162691827.USD","LU0868494617.USD","LU1430594728.SGD","LU2125154935.USD","FHLC","LU1291159041.SGD","SG9999014542.SGD","BK4516","LU1069347547.HKD","BK4559","LU1116320901.HKD","IE0009355771.USD","LU1162221912.USD","TRUH","LU0265550946.USD","LU2360032135.SGD","LU1934455194.USD","SG9999001440.SGD","LU2089984988.USD","IXJ","LU1037948897.HKD","LU0965509283.SGD","SG9999001176.USD","LU0234572021.USD","LU1917777945.USD","SG9999015358.SGD","BMED","LU0823416689.USD","LU0472753341.HKD","LU1941712348.USD","LU0070302665.USD","LU2125154778.USD","LU1037948541.HKD","LU0072461881.USD","SG9999013999.USD","LU1989772840.SGD","LU1061106388.HKD","LU0058720904.USD","IE00BBT3K403.USD","HRTS","LU0057025933.USD","LU1093756325.SGD","LU2125909593.SGD","SG9999014575.USD","XLV","LU1066051498.USD","LU0130102774.USD","LU1974910355.USD","LU2433249047.HKD","RXL","LU0211331839.USD","LU0289739343.SGD","LU0130517989.USD","LU1585245621.USD","LU0511384066.AUD","LU2491049909.HKD","LU0868494708.USD","LU1032466523.USD","LU0980610538.SGD","BK4585","MRK","IE00BJT1NW94.SGD","LU0266013472.USD","IHE","LU0006306889.USD","LU0122379950.USD","LU2324357040.USD","LU0965508806.USD","LU2023250843.SGD","IE00BN8TJ469.HKD","GDOC","LU0859254822.USD","LU2468319806.SGD","LU2461242641.AUD","LU0289739699.SGD","LU0477156953.USD","LU0203347892.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","FTXH","LU2112291526.USD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU1571399168.USD","SG9999015341.SGD","BK4588","SG9999014567.USD","LU1934455277.USD","PAWZ","LU0265550359.USD","LU1983299246.USD","LU0648001328.SGD","VHT","LU2357627491.SGD","LU0689626769.HKD","LU2491050071.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492754","title":"Merck Has Two Overlooked Pipeline Catalysts Coming Before Year-End, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492754","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492754?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:03","pubTimestamp":1790269423,"startTime":"0","endTime":"0","summary":"Merck  has two under-the-radar phase III catalysts due before year-end that carry low investor expectations, creating a positively skewed set up if either reads out positive, UBS said in a note emailed Thursday.The nearer one is phase III BRUNELLO data on MK3000, a Wnt agonist from Merck's 2024 Eyebio deal, in diabetic macular edema. Data is expected around an Oct. 10 placeholder at the American Academy of Ophthalmology meeting, with primary completion for the trial set for Sept. 30, the bank said.UBS said the drug need to prove non-inferiority to Lucentis on vision gains to meet its primary endpoint, while investors will likely demand superiority on a secondary endpoint.The bank also flagged phase III TL1A data due from a second ulcerative colitis study, acquired via the 2023 Prometheus deal, as a second overlooked catalyst.UBS maintained its buy rating on the stock with the price target of $175.Price: 149.64, Change: +1.55, Percent Change: +1.05","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1989772923.USD","LU2023250504.SGD","FHLC","LU1201861249.SGD","LU1989772840.SGD","LU0985320562.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU0320765489.SGD","LU1923622614.USD","LU0265550359.USD","VHT","LU0965509010.AUD","LU0868494617.USD","XLV","IHE","LU0130517989.USD","LU2089984988.USD","LU0289739699.SGD","LU2023250843.SGD","LU0124676726.USD","LU0072461881.USD","SG9999014559.SGD","IE00B2B36J28.USD","LU1162221912.USD","BK4516","IE00BLSP4452.SGD","LU1699723380.USD","BMED","LU1116320737.USD","IE0002141913.USD","LU1941712264.USD","LU0098860793.USD","LU2433249047.HKD","PAWZ","LU0058720904.USD","IE00BN8TJ469.HKD","RXL","LU1934455277.USD","LU1061106388.HKD","LU0472753341.HKD","LU0057025933.USD","LU0477156953.USD","LU2491050071.SGD","SG9999015358.SGD","LU0266013472.USD","LU1929549753.HKD","LU1291159041.SGD","LU1571399168.USD","LU2324357040.USD","SG9999001176.SGD","SG9999014567.USD","IE00BFTCPJ56.SGD","LU1934455863.HKD","LU2357627491.SGD","LU2125154778.USD","SG9999001440.SGD","LU1069347547.HKD","LU1066053197.SGD","LU1983299246.USD","BK4585","LU1093756325.SGD","LU2125909247.SGD","TRUH","BK4533","LU0689626769.HKD","SG9999001176.USD","LU2112291526.USD","BK4534","LU0265550946.USD","LU0980610538.SGD","SG9999015341.SGD","LU1974910355.USD","LU0006306889.USD","LU0122379950.USD","LU0238689110.USD","LU1917777945.USD","LU1989771016.USD","IE000M9KFDE8.USD","LU2491049909.HKD","SG9999014575.USD","LU0208291251.USD","LU0965508806.USD","LU1585245621.USD","LU0648001328.SGD","LU1057294990.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","IE0009355771.USD","LU2361045086.USD","LU1093756168.USD","IE00BBT3K403.USD","LU0861579265.USD","LU0289961442.SGD","FTXH","LU2125909593.SGD","LU2461242641.AUD","LU0106261372.USD","LU0162691827.USD","GDOC","LU0320765646.SGD","LU1037948541.HKD","IE00BSNM7G36.USD","IYH","MRK","LU0070302665.USD","LU0234572021.USD","BK4588","LU0289739343.SGD","LU0965509283.SGD","LU0942090050.USD","SG9999013999.USD","LU0211331839.USD","LU2361044949.HKD","LU0859254822.USD","HRTS","LU2468319806.SGD","BK4007","IXJ","LU1023059063.AUD","BK4559","LU1035773651.USD","LU1066051811.HKD","LU0868494708.USD","LU2106854487.HKD","LU2360032135.SGD","LU0203347892.USD","JDOC","LU1430594728.SGD","LU0965509101.SGD","LU1032466523.USD","IE00BLSP4239.USD","LU0069063385.USD","SG9999002224.SGD","LU0203345920.USD","LU0432979614.USD","LU2491050154.USD","PPH","LU2361044865.SGD","SG9999002232.USD","LU0130102774.USD","LU1066051498.USD","SG9999014542.SGD","LU1116320901.HKD","LU2125154935.USD","LU1066051225.USD","LU1941712348.USD","LU0511384066.AUD","BK4550","LU1934455194.USD","IE00BJT1NW94.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492787","title":"Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492787","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492787?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:02","pubTimestamp":1790269368,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics'  lead program of long-acting IL-23 in moderate-to-severe psoriasis maintains a \"competitive profile\" after positive week 28 clinical data, UBS said in a Wednesday note.Oruka's ORKA-001 increased its Psoriasis Area and Severity Index-100 score, which represents the complete resolution of psoriasis, to 71% from 64% in week 16. This compares favorably with rival product, AbbVie's  Skyrizi, which rose to 53% from 43% in the same period, UBS analysts said.The safety data was also consistent with prior data, as treatment-emergent adverse events were 36% in the period of week 16 to 28, compared with 51% during week zero to 16. There were also no injection site reactions and no impact of anti-drug antibodies on safety, efficacy and pharmacokinetics, the analysts noted.The analysts said they are confident in the company's multiple additional readouts later in the year to be positive, \"given the de-risking provided by previous datasets\".UBS' rating on the company's stock is b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029864427.USD","PPH","BK4585","ORKA","JDOC","AGNG","LU1093756168.USD","MEDX","LU2237443549.SGD","IE000WAW04H5.SGD","LU0124676726.USD","LU0256863811.USD","LU0795875169.SGD","RXL","LU0320765646.SGD","VHT","BK4588","IXJ","LU0198837287.USD","LU0985320562.USD","LU0256863902.USD","IE00BN8TJ469.HKD","FHLC","FTXH","TRUH","LU1003077747.HKD","SG9999001440.SGD","IE00B19Z3B42.SGD","BK4007","LU0114720955.EUR","LU1934455863.HKD","LU2133065610.SGD","LU0511384066.AUD","IE000F7OJYX1.SGD","LENZ","IYH","IE00BVYPNW00.USD","LU0432979614.USD","GLAM","LU0289961442.SGD","LU0395794307.EUR","XLV","SG9999015986.USD","IE00BLSP4239.USD","PJP","BK4550","LU0211327993.USD","ABBV","LU2129689514.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670929224","title":"BMY’s Lung Cancer Combo Study Completion Adds Quiet Support to Its Immuno-Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2670929224","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670929224?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:30","pubTimestamp":1790267422,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb Co. (BMY) has completed a Phase 1 stu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bmys-lung-cancer-combo-study-completion-adds-quiet-support-to-its-immuno-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bmys-lung-cancer-combo-study-completion-adds-quiet-support-to-its-immuno-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0237698245.USD","LU1430594728.SGD","LU1718418525.SGD","BK4007","LU0321505439.SGD","LU1093756168.USD","LU0267386448.USD","BK4534","LU2596442595.SGD","LU0096364046.USD","LU1236620834.HKD","LU1261432733.SGD","LU0306806265.USD","BK4588","IE00BFXG1179.USD","IHE","IE0009355771.USD","LU1670711123.USD","LU2242652126.USD","BK4581","LU2242646821.SGD","BK4585","LU1883839398.USD","LU1670710588.SGD","LU0225284248.USD","LU1236620750.USD","LU1074936037.SGD","LU1868837136.USD","LU0225771236.USD","LU1585245621.USD","LU0868494617.USD","FTXH","IE00BFTCPJ56.SGD","LU1868836591.USD","BMY","LU1291159041.SGD","LU1323610961.USD","LU1868837300.USD","LU0985481810.HKD","IE0002141913.USD","LU0306807586.USD","LU2125154935.USD","LU2125154778.USD","LU1670710661.SGD","LU0432979614.USD","LU1032466523.USD","LU1571399168.USD","BK4559","LU0321505868.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670149441","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2670149441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670149441?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:00","pubTimestamp":1790265608,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeEverpure IncP.N+18.4%Charles River Laboratories International, Inc.CRL.N+5.2%Valero Energy CorpVLO.N+4.0%Illumina IncILMN.OQ+3.7%Eli Lilly and CompanyLLY.N+3.4%Bottom PerformersPercent ChangeMGM Resorts InternationalMGM.N-10.2%Gen Digital Inc.GEN.OQ-8.2%First Solar, Inc.FSLR.OQ-7.5%Rollins IncROL.N-6.2%Bloom Energy CorporationBE.N-5.9%As of 12:00 p.m., the S&P 500.SPXlost 33.07 points, or 0.43%, to 7,673.06 and had posted 10 new 52-week highs and 36 new lows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL8N45G1NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","SG9999014880.SGD","LU2023250504.SGD","IE00B1BXHZ80.USD","SG9999015945.SGD","PXI","LU1366192091.USD","XDTE","LU2750360997.AUD","LU0390134368.USD","LU1035775433.USD","LU0323239441.USD","RSPN","LU1280957306.USD","LU2357125470.USD","LU2361044949.HKD","LU0106261372.USD","BMAY","MHIP","LU0353189680.USD","SPXU","IE0005OL40V9.USD","BE","ILDR","JEPI","LU0820561818.USD","FSLR","LU0203201768.USD","VEU","SPMO","GNOM","LU2168564495.EUR","IXJ","VHT","LU1983299162.USD","BK4121","LU0079474960.USD","LU2462157665.USD","DBSC","LU0354030438.USD","LU0882574139.USD","SGXZ31699556.SGD","LU2249611893.SGD","LU0889565916.HKD","LU2125909759.SGD","IE00BKDWB100.SGD","SMAX","IE00B3CCJ633.GBP","SPLV","SDS","IYH","LU2108987350.USD","LU1868836591.USD","IE00BGHQF417.EUR","LU0943347566.SGD","SG9999001440.SGD","SG9999001176.USD","LU2324357040.USD","BK4097","GSLC","FENY","IE00BK4W5M84.HKD","LU2168564222.USD","ELIL","IHE","LU2272731600.USD","LU0353189763.USD","IE00B2Q91V27.USD","BEX","HRTS","LU0964807845.USD","ITOT","LU2063271972.USD","RSPG","LU2294711713.HKD","IE00B2B36J28.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2461242641.AUD","SGXZ57979304.SGD","IE0002141913.USD","LU0957808578.USD","NOBL","LU0823434740.USD","LU2756315318.SGD","SPY","LU2028103732.USD","IE00B3CCJ963.GBP","IVW","SPUU","LU0061475181.USD","LU0476273544.USD","LU0114720955.EUR","LU0256863811.USD","PPH","LU1988902786.USD",".SPX","LU0345781412.USD","LU1145028129.USD","LU1992135472.HKD","LU2491049909.HKD","SG9999015986.USD","IBAT","VTV","LU1868836914.USD","SFY","LU2286300806.USD","IE00BJT1NW94.SGD","LU0432979614.USD","SCHB","MEDI","IVV","LU2125909916.SGD","BK4585","SPXS","SG9999017495.SGD","IE00BWXC8680.SGD","LU1023059063.AUD","LU0345770308.USD","YSPY","CTEC","LU0124384867.USD","SH","TMED","LU2750360641.GBP","SGXZ51526630.SGD","LU2237443549.SGD","ICLN","LU2543165471.USD","LU2471134879.HKD","BK4170","TSPY","LU0354030511.USD","HYDR","LU2089283258.USD","BK4150","LLY","LU1868837300.USD","PXE","LU1623119135.USD","IE00BK4W5L77.USD","LU0320765992.SGD","BK4138","LU0456855351.SGD","SG9999014906.USD","AGNG","CURE","LU0724618433.USD","LU0154245756.USD","LU0640476718.USD","BEC","IE00B4JS1V06.HKD","LU0630314457.HKD","PJP","XLV","LU0256863902.USD","BK4596","LU0689472784.USD","LU1720051108.HKD","SG9999015952.SGD","LU2237443382.USD","ILMN","SPHD","LU1291159041.SGD","LU2111349929.HKD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2746668974.SGD","LU0316494557.USD","LU0300736492.USD","SG9999018865.SGD","XLE","LU2089984988.USD","LU0368265418.SGD","LU0133085943.USD","LU0312595415.SGD","LU1983299246.USD","LU2322448957.HKD","PUL","BK4535","RSPU","SPHQ","LU2756315664.SGD","LU0757428866.USD","LU0266013472.USD","SG9999001176.SGD","LU2456880835.USD","LU2087625088.SGD","LU2272731782.SGD","LU1815336760.USD","LU0788109394.HKD","SPYM","BEZ","FTXH","GPIX","LU1992135399.USD","LLII","BK4541","LU1548497426.USD","LU2471134796.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","LU1923622291.USD","RXL","TRUN","CNRG","ZAP","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","LU1712237335.SGD","LU1814569148.SGD","SPYQ","TRUH","IE00BFSS7M15.SGD","MEDX","LU1815336091.USD","LU0417517546.SGD","LU0238689110.USD","LU0210536198.USD","LU0385154629.USD","LU0882574055.USD","LU1978683503.SGD","IJR","IE0009355771.USD","LU0820561909.HKD","LU2272731865.HKD","IE00BFMHRM44.USD","SPUS","LU2746668461.USD","LU0158827781.USD","LU2473716301.USD","LU2491050154.USD","GNMX","LU1585245621.USD","LU2298322129.HKD","IE00B7KXQ091.USD","LU2023250330.USD","LU0820562030.AUD","EGGY","LU0058720904.USD","LU0471298694.HKD","LU0466842654.USD","WATS","BK4561","LU0823434583.USD","IVE","LU0672654240.SGD","LU2023251221.USD","LU2168564065.EUR","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","LU0345780950.USD","IE00B2PGVK34.USD","UPRO","SPYV","IE0004445239.USD","LU0109391861.USD","VCLN","LU0198837287.USD","LU0266512127.USD","LU1267930730.SGD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LLYZ","P","GDOC","LU0708995401.HKD","LU2271345857.HKD","LU0158827948.USD","LU1232071149.USD","LU0823421416.USD","LU1720051017.SGD","LU2106854487.HKD","LU1974910355.USD","BK4588","VOOG","HIBL","LU0786609619.USD","RSP","LU0006306889.USD","VTWG","LU0323240290.USD","LU1691799644.USD","DRLL","IE00BJLML261.HKD","VV","LU2168563687.JPY","ELIS","LU1551013342.USD","LU1093756325.SGD","LU2168564149.EUR","CRL","XLG","LU1127390331.HKD","IE0009354923.USD","IE0004445015.USD","LU0122376428.USD","LU2237443465.HKD","LLYX","MMAX","IE00BFSS8Q28.SGD","XYLD","LU2048586759.USD","LU0094547139.USD","IJH","LU0823414478.USD","LU0174119429.USD","LU1917777945.USD","LU2264538146.SGD","SCHX","LU2237443622.USD","LU0266512473.USD","SSO","LU2361045086.USD","VTI","BK4516","LU0096364046.USD","LU0097036916.USD","SPYD","SPYU","BEG","LU1323610961.USD","LU0225283273.USD","LU2506951792.HKD","LU0170899867.USD","BK4007","IYE","SG9999018857.SGD","LU2211814178.USD","SPYG","LU1069344957.HKD","LU2236285917.USD","LU2468319806.SGD","HIBS","TAN","SPGP","UPGR","VBK","WDNA","LU1868837136.USD","ETFT","GEN","ODDZ","CANC","ROL","OZEM","LU0471298777.SGD","LU0444971666.USD","LU1430594728.SGD","THNR","LU1989771016.USD","GXPE","SPDN","LU0029874061.USD","LU0128526141.USD","LU1061106388.HKD","SG9999013999.USD","BK4519","SGXZ81514606.USD","ALLW","RSPA","LU0234572021.USD","BK4534","SG9999014898.SGD","LU2112291526.USD","LU0823416689.USD","SMOG","SPXL","LU1093756168.USD","LU0787776722.HKD","GB00BDT5M118.USD","SG9999015978.USD","IE00BGHQF524.EUR","LU1064131342.USD","BK4120","LU2265009873.SGD","IE00B775H168.HKD","BK4141","LU2602419157.SGD","ACWI","IE00BJJMRX11.SGD","LU0683600562.USD","CRAK","SG9999014914.USD","BK4599","IE00B1XK9C88.USD","BK4530","MOAT","LU2237443978.SGD","BK4182","VLO","LU2471134523.USD","WEEI","FRNW","LU0444973449.USD","LU2417539215.USD","LU2462591350.SGD","LU2361044865.SGD","LU1868836757.USD","LU2896262040.SGD","LU1979441026.SGD","LU2237438978.USD","LU1804176565.USD","IE00BN29S564.USD","LU0203202063.USD","LU0323591593.USD","LU2237443895.HKD","LU2322448791.USD","LU2089284900.SGD","BK4548","LU0154245673.USD","SPYH","LU1571399168.USD","DMAX","MGM","LU0456854461.SGD","IE00BSNM7G36.USD","VOO","LU2213496289.HKD","LU2471134952.CNY","BK4581","FHLC","TNGY","LU0345770993.USD","LU0823421333.USD","JDOC","LU1642822529.SGD","SIMS","LU2491050071.SGD","LU2552382132.HKD","LU0823414551.USD","LU0122379950.USD","IEO","IE00BJJMRY28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149622","title":"Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149622","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149622?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:15","pubTimestamp":1790259318,"startTime":"0","endTime":"0","summary":"• FDA approved Eli Lilly's once-weekly basal insulin Onswik for type 2 diabetes.\n• Eli Lilly reported $65.18B annual revenue and $20.64B net profit.\n• Analysts rate the stock as Buy with an average price target of $1306.81.","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185188-market-movers-lly-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU2461242641.AUD","LU1868837136.USD","LU0323591593.USD","LU2237443978.SGD","LU0109391861.USD","LU2063271972.USD","ILDR","LU2237443549.SGD","OZEM","IE00BJJMRY28.SGD","LU0061475181.USD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU2237443622.USD","LU2271345857.HKD","IE00BKPKM429.USD","IXJ","LU0210536198.USD","LU1629891620.HKD","LU0823416689.USD","LU2552382215.SGD","LU2602419157.SGD","LU1988902786.USD","LU0203202063.USD","LU1366192091.USD","LU1974910355.USD","LU0640476718.USD","LU2023250330.USD","FTXH","LU2089283258.USD","BK4534","MHIP","LU2211815571.USD","LU1868836757.USD","LU0266013472.USD","LU1814569148.SGD","LU2168564222.USD","LU1979441026.SGD","IYH","LU1267930730.SGD","SG9999015945.SGD","IE00BKDWB100.SGD","SG9999015986.USD","LU1989771016.USD","LU2756315318.SGD","LU1868836591.USD","LU2361044949.HKD","LU2237443895.HKD","IE00BJJMRX11.SGD","LU1548497426.USD","CANC","LU2237438978.USD","LU0823434583.USD","LU0353189680.USD","MEDX","LU2357305700.SGD","LU0122379950.USD","LU0096364046.USD","LU0786609619.USD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","SG9999001176.SGD","BK4007","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE00BFSS7M15.SGD","LU0320765059.SGD","LU1023059063.AUD","LU2462591350.SGD","LLII","LU0316494557.USD","LU0820561909.HKD","TRUH","WDNA","IE00B1XK9C88.USD","LU1551013425.SGD","BK4516","LU1035775433.USD","LU2237443465.HKD","LU1069344957.HKD","IE00BN29S564.USD","LU1057294990.SGD","LU2168564065.EUR","LU0006306889.USD","LU0385154629.USD","BK4581","LU2168563687.JPY","LU2028103732.USD","SG9999001176.USD","LU2168564149.EUR","LU1280957306.USD","LU1093756325.SGD","LLYZ","IE00BJLML261.HKD","LU2462157665.USD","SGXZ51526630.SGD","LU2471134523.USD","LU0225283273.USD","LU0689472784.USD","LU1127390331.HKD","FHLC","LU1691799644.USD","LU0787776722.HKD","PJP","LU0320765992.SGD","LU1064131342.USD","LU2756315664.SGD","LU2896262040.SGD","LU2471134879.HKD","IE0004445015.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU1323610961.USD","LU2417539215.USD","LU0289739699.SGD","LU2168564495.EUR","LU0820562030.AUD","LU2468319806.SGD","LU2264538146.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU0823434740.USD","GDOC","LU0708995401.HKD","IE00BJT1NW94.SGD","LU0354030511.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU0882574055.USD","BK4585","LU2491050154.USD","LU0432979614.USD","IE00BWXC8680.SGD","SG9999015978.USD","SG9999018865.SGD","LU2491050071.SGD","LU0198837287.USD","LU2265009873.SGD","HRTS","LU1551013342.USD","LU0106261372.USD","SG9999013999.USD","LU0256863902.USD","LU0964807845.USD","AGNG","SG9999014880.SGD","BK4588","LU0889565916.HKD","IE00B4JS1V06.HKD","LU2023251221.USD","SG9999017495.SGD","LU1623119135.USD","LU0471298777.SGD","LU2106854487.HKD","LU2108987350.USD","LU0079474960.USD","LU2746668461.USD","VHT","LU2750360997.AUD","LU0353189763.USD","LU1720051108.HKD","LU0471298694.HKD","LU0109394709.USD","LU0114720955.EUR","SG9999014906.USD","LU0174119429.USD","SG9999018857.SGD","LU2023250504.SGD","IHE","LU1145028129.USD","BK4599","ELIL","LU1093756168.USD","LU0094547139.USD","IE0004445239.USD","LU0456855351.SGD","LU2324357040.USD","LU2491049909.HKD","LU0354030438.USD","RXL","LU2552382132.HKD","LU0238689110.USD","LU2089284900.SGD","IE00BK4W5L77.USD","LU2750360641.GBP","LU0417517546.SGD","THNR","ELIS","LU0158827948.USD","LU1868837300.USD","LU2111349929.HKD","LU0058720904.USD","TMED","LLYX","IE00BFTCPJ56.SGD","GB00BDT5M118.USD","SGXZ57979304.SGD","LU0466842654.USD","LU0882574139.USD","LU1291159041.SGD","LU1917777945.USD","LU1983299246.USD","LU0158827781.USD","LU2237443382.USD","LU2361045086.USD","LU2746668974.SGD","LU0256863811.USD","LU0820561818.USD","BK4533","LU0097036916.USD","IE00B775H168.HKD","LU2456880835.USD","LU2213496289.HKD","LLY","LU1804176565.USD","LU1712237335.SGD","LU0943347566.SGD","LU0133085943.USD","XLV","LU0234572021.USD","LU1232071149.USD","LU0683600562.USD","LU2112291526.USD","SG9999014898.SGD","IE0002141913.USD","LU0203201768.USD","IE00BJJMRZ35.SGD","PPH","CURE","MEDI","LU2471134952.CNY","SGXZ81514606.USD","LU2087625088.SGD","LU2360106947.USD","LU1868836914.USD","LU2089984988.USD","LU2471134796.USD","IE0009355771.USD","LU0345770308.USD","LU1720051017.SGD","LU2236285917.USD","LU2552382058.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149540","title":"Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149540","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149540?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:46","pubTimestamp":1790257597,"startTime":"0","endTime":"0","summary":"BUZZ-Lilly's next-gen obesity efforts could tip scales further in its favor, Citi says** Eli LillyLLY.Nis expected to present mid-stage data next week on eloralintide, its next-generation obesity drug candidate, in combination with its blockbuster weight-loss drug Zepbound, chemically known as tirzepatide** Citi analysts say the data will be a test of whether eloralintide can extend tirzepatide's efficacy without compromising tolerability or persistence** Eloralintide belongs to the class of drugs that mimic the pancreatic hormone amylin with the potential of less severe side effects than the popular GLP-1 class of drugs** Citi says 16 to 18% weight loss would be a \"solid readout with over 18% being a clean win to further diversify Lilly's obesity portfolio, expand coverage across patient needs, and provide greater treatment flexibility\"** A 9-milligram dose of eloralintide had helped patients lose about20.1%or 21.3 kgs in a mid-stage study last year** Up to last close, LLY up ~7% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","LU2468319806.SGD","SG9999015986.USD","LU0823434583.USD","IE00B775H168.HKD","IXJ","AGNG","LU1712237335.SGD","SG9999015945.SGD","LU0345770308.USD","LU1691799644.USD","LU1057294990.SGD","SG9999015952.SGD","SG9999013999.USD","IE00B1XK9C88.USD","LU0061475181.USD","LU2211815571.USD","SGXZ81514606.USD","IE00BJJMRY28.SGD","LU1145028129.USD","LU1323610961.USD","IE00BK4W5M84.HKD","LU2112291526.USD","LU0106261372.USD","LU0256863811.USD","LU1917777945.USD","LU2462591350.SGD","LU2106854487.HKD","LU2471134879.HKD","LU1093756168.USD","BK4581","SG9999014880.SGD","LU1988902786.USD","LU0266013472.USD","LU2168564149.EUR","LU2265009873.SGD","LU0058720904.USD","LU0456855351.SGD","LU0316494557.USD","LU0256863902.USD","IE0009355771.USD","LU2237443465.HKD","LU2237443382.USD","HRTS","LU2213496289.HKD","IE00B7KXQ091.USD","LLYX","LU2237443978.SGD","LU1127390331.HKD","SG9999017495.SGD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2471134952.CNY","LU0964807845.USD","ELIL","SG9999018857.SGD","LU2750360997.AUD","LU0289739699.SGD","LU2108987350.USD","SG9999001176.USD","LU1280957306.USD","LU0158827948.USD","LU0672654240.SGD","PPH","SG9999001176.SGD","XLV","LU0097036916.USD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2552382058.USD","LU0238689110.USD","LU1720051108.HKD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU0198837287.USD","LU0353189680.USD","LU0354030438.USD","LU1551013425.SGD","BK4007","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1069344957.HKD","IHE","LU2023250504.SGD","LU2471134523.USD","LU0786609619.USD","IE00BN29S564.USD","LU2750360641.GBP","LU1868836757.USD","LU0203201768.USD","LU0385154629.USD","LU2360106947.USD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU0079474960.USD","LU2552382215.SGD","LU0158827781.USD","RXL","LU2552382132.HKD","LU0323591593.USD","LU1974910355.USD","SG9999018865.SGD","LU2168564222.USD","LU1623119135.USD","BK4533","MEDX","LU0225283273.USD","GDOC","LU2089283258.USD","ILDR","LU1232071149.USD","LU1979441026.SGD","LU2063271972.USD","LU2746668974.SGD","LLII","LU1804176565.USD","LU0320765992.SGD","LU1814569148.SGD","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU1291159041.SGD","IE00BK4W5L77.USD","LU1064131342.USD","LU2023251221.USD","OZEM","LU1023059063.AUD","LLYZ","CURE","LU1868836591.USD","LU2462157665.USD","LU2471134796.USD","LU1035775433.USD","LLY","LU1989771016.USD","LU2361044949.HKD","LU2361045086.USD","SG9999015978.USD","SGXZ51526630.SGD","LU2361044865.SGD","LU0471298777.SGD","SGXZ99366536.SGD","LU2491049909.HKD","LU2602419157.SGD","LU0320765059.SGD","LU1983299246.USD","LU1366192091.USD","BK4599","IE0005OL40V9.USD","LU0210536198.USD","IE0004445015.USD","IYH","LU2028103732.USD","LU0122379950.USD","LU2324357040.USD","LU1548497426.USD","LU0174119429.USD","LU0234572021.USD","LU0109394709.USD","IE00BJLML261.HKD","LU2168563687.JPY","LU0353189763.USD","IE00BJT1NW94.SGD","LU0882574139.USD","SGXZ57979304.SGD","LU2357305700.SGD","LU2237443622.USD","LU1061106388.HKD","BK4588","PJP","LU2756315318.SGD","LU0823416689.USD","TRUH","LU0820561818.USD","IE00BWXC8680.SGD","LU0354030511.USD","LU0432979614.USD","LU2456880835.USD","WDNA","BK4585","LU2237443895.HKD","JDOC","LU0094547139.USD","IE00BFSS7M15.SGD","LU0683600562.USD","BK4534","LU0823434740.USD","LU2237438978.USD","SG9999014914.USD","LU0640476718.USD","FTXH","LU2896262040.SGD","MEDI","VHT","IE00B1BXHZ80.USD","LU2264538146.SGD","LU1629891620.HKD","LU2271345857.HKD","LU2168564065.EUR","LU2461242641.AUD","LU0006306889.USD","IE0004445239.USD","LU0345770993.USD","THNR","LU0417517546.SGD","IE0002141913.USD","LU2236285917.USD","LU0466842654.USD","LU2237443549.SGD","ELIS","IE00B4JS1V06.HKD","LU1868837300.USD","LU0820561909.HKD","IE00B2B36J28.USD","LU0689472784.USD","LU2746668461.USD","TMED","LU1093756325.SGD","SG9999014898.SGD","LU2087625088.SGD","LU2089984988.USD","LU0203202063.USD","IE00BKDWB100.SGD","LU2491050071.SGD","GB00BDT5M118.USD","LU0708995401.HKD","LU2023250330.USD","LU2417539215.USD","LU0133085943.USD","CANC","LU0820562030.AUD","LU2111349929.HKD","BK4516","IE00BJJMRX11.SGD","LU1720051017.SGD","LU2491050154.USD","MHIP","LU1551013342.USD","SG9999014906.USD","LU1267930730.SGD","LU0109391861.USD","LU2168564495.EUR","LU0096364046.USD","LU1868837136.USD","LU0943347566.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493077","title":"Alert on EOG CFO Appointment Incorrectly Tagged to J&J Withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493077?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:23","pubTimestamp":1790256223,"startTime":"0","endTime":"0","summary":"ADVISORY-Alert on EOG CFO appointment incorrectly tagged to J&J withdrawnSept 24 (Reuters)-An alert from EOG ResourcesEOG.Nannouncing the appointment of a new CFO was inadvertently tagged to Johnson &","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUAS8RR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0000B7K699.USD","FTXH","PXE","RXL","LU0203347892.USD","IE00BBT3K403.USD","FTXN","BK4550","LU2471134879.HKD","FHLC","LU0994945656.USD","LU2430703251.USD","EOG","IEO","LU0208291251.USD","LU1066053197.SGD","GDOC","BMED","LU0426412945.USD","LU1244550494.USD","LU2756315664.SGD","LU0345769631.USD","LU1221951129.SGD","LU0943347566.SGD","DRLL","IXJ","SGXZ80539844.SGD","LU1032955483.USD","LU2112291526.USD","BK4559","MEDX","IE00BGHQF631.EUR","JDOC","XLV","IHE","FCG","PJP","LU0648001328.SGD","LU1280957306.USD","LU0266512127.USD","BK4504","LU0203345920.USD","TRUH","VHT","JNJ","LU2237438978.USD","LU0964807845.USD","LU0300736492.USD","IYH","OILT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493147","title":"EOG Resources Announces Ann Janssen's Retirement and Jeff Hibbard as Next CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493147?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:10","pubTimestamp":1790255400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUAS8RR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VHT","IE00BBT3K403.USD","FTXN","LU0203347892.USD","GDOC","FHLC","XLV","FCG","IE00B2Q91V27.USD","IHE","DRLL","OILT","RXL","LU1061106388.HKD","LU1057294990.SGD","LU0882574055.USD","LU1244550494.USD","LU0234570918.USD","LU0788109394.HKD","LU1261432733.SGD","IE0009355771.USD","LU1291159041.SGD","LU1551013425.SGD","LU2896262040.SGD","BK4007","IE00BVYPNV92.GBP","BMED","MEDX","PJP","PXE","IE0002141913.USD","BK4568","IE00BLSP4452.SGD","BK4533","LU2750360997.AUD","LU0345769631.USD","TRUH","IYH","LU0345770308.USD","BK4585","LU2236285917.USD","LU0889566641.SGD","LU0640476718.USD","JDOC","FTXH","LU0130517989.USD","IXJ","JNJ","IEO","EOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462942","title":"Merck's Drug for Diabetes-Related Eye Disease Meets Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462942","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462942?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:04","pubTimestamp":1790247879,"startTime":"0","endTime":"0","summary":"UPDATE 3-Merck's drug for diabetes-related eye disease meets trial goalSept 24 (Reuters)-MerckMRK.Nsaid on Thursday its injectable drug for a serious eye disease affecting people with diabetes was as ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015341.SGD","HRTS","LU1989771016.USD","IYH","IHE","LU0289739343.SGD","XLV","RXL","SG9999002224.SGD","BK4559","LU2125154935.USD","LU1934455277.USD","TRUH","JDOC","GDOC","LU0472753341.HKD","BMED","LU1066051498.USD","LU2433249047.HKD","SG9999001440.SGD","LU0122379950.USD","IE00B2B36J28.USD","LU0511384066.AUD","LU0203347892.USD","LU0965509283.SGD","BK4007","VHT","LU0985320562.USD","MRK","PAWZ","LU0098860793.USD","LU0289739699.SGD","LU2324357040.USD","LU2023250504.SGD","LU0432979614.USD","BK4550","FTXH","FHLC","LU0477156953.USD","LU2491049909.HKD","LU0006306889.USD","PPH","IE000M9KFDE8.USD","IXJ","LU1116320901.HKD","LU1061106388.HKD","LU1989772840.SGD","SG9999014559.SGD","BK4516","LU0266013472.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669629644","title":"Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2669629644","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669629644?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:03","pubTimestamp":1790247822,"startTime":"0","endTime":"0","summary":"Health Canada approves AbbVie’s EPKINLY combo for relapsed or refractory follicular lymphoma in adultsHealth Canada cleared AbbVie’s EPKINLY (epcoritamab) with lenalidomide, rituximab for relapsed or ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDLbtn36S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","LU1934455863.HKD","SG9999015978.USD","VHT","LU1496350171.SGD","SG9999011175.SGD","LU2237443465.HKD","LU0553294199.USD","IE00BLSP4239.USD","LU1291159041.SGD","FTXH","AGNG","LU0310800379.SGD","LU0965509101.SGD","PJP","LU2347655073.USD","RXL","LU0708994859.HKD","IXJ","LU0661504455.SGD","LU0289961442.SGD","LU2237443895.HKD","PPH","LU1093756168.USD","SG9999003800.SGD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","ABBV","IYH","LU0114720955.EUR","LU0310799852.SGD","MEDX","LU0820561909.HKD","LU1037948897.HKD","LU0417517546.SGD","BK4533","IE0002270589.USD","IE000MB6IJN5.SGD","IE00BGHQF631.EUR","LU2357305700.SGD","IE00BN8TJ469.HKD","GLAM","LU0859254822.USD","JDOC","IE00BJJMRZ35.SGD","LU0069063385.USD","XLV","TRUH","LU1670627923.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":12,"totalSize":324,"code":"91000000","status":"200"}]}}